P3 Health Partners (PIII) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
9 Jun, 2026Opening remarks and agenda
Meeting conducted virtually with introductions of key officers and explanation of meeting procedures.
Agenda and rules of conduct provided on the virtual meeting webpage; voting and Q&A procedures explained.
Shareholder proposals
Four proposals presented: election of three Class II directors, ratification of BDO USA, P.C. as auditor, advisory approval of executive compensation, and approval for issuance of up to 3,341,130 shares upon warrant exercise.
Overview of voting outcomes
Quorum confirmed and all four proposals approved based on preliminary Inspector of Election report.
Final vote tally to be published within four business days in a Form 8-K filing.
Partial view of Summaries dataset, powered by Quartr API
Latest events from P3 Health Partners
- Raised 2026 guidance to $1.5B–$1.6B revenue and $80M–$110M adjusted EBITDA, driven by value-based care.PIII
Investor presentation - Q2 2026 delivered strong profitability, raised guidance, but ongoing liquidity risks persist.PIII
Q2 2026 - Q1 2026 delivered $3M net income and $26M adjusted EBITDA, but liquidity risks remain.PIII
Q1 2026 - 2026 guidance targets $1.5B–$1.65B revenue and $20M–$60M adjusted EBITDA amid strategic growth.PIII
Investor presentation - Key votes include director elections, auditor ratification, and approval of new share issuance.PIII
Proxy filing - Revenue up 26% but net loss widened to $102.9M; liquidity risks remain.PIII
Q3 2024 - Q2 revenue up 15% to $379M, but profitability declined and liquidity risks persist.PIII
Q2 2024 - Q1 2025 saw revenue and membership decline, improved MLR, and ongoing liquidity risks.PIII
Q1 2025 - 2025 guidance reaffirmed with profitability expected, despite a deeper 2024 net loss.PIII
Q4 2024